Literature DB >> 12491016

Endovascular treatment of central vein stenoses and/or occlusions in hemodialysis patients.

Jana Masková1, Jana Komárková, Jirí Kivánek, Jan Danes, Marcela Slavíková.   

Abstract

PURPOSE: To report our experience and results with the endovascular treatment of central vein stenoses and occlusions in hemodialysis patients.
METHODS: Between October 1999 and August 2001 (22 months) we performed 22 interventional procedures in 14 hemodialysis patients (8 women, 6 men) ranging in age from 38 to 87 years (mean 76 years). The indication for intervention was stenosis (n = 10) or occlusion (n = 4) of a central vein in the upper arm used for dialysis in patients with arm swelling and/or shunt malfunction. All patients had a previous history of subclavian vein cannulation. There were six percutaneous transluminal angioplasties (PTAs) and eight primary stent placements and eight repeat interventions. Seven were for restenoses and one for early occlusion, with two secondary stent placements and six PTA of in-stent stenoses. In two patients a second stent was implanted. The mean follow-up was 8.5 months (range 1-19 months). All stents were self-expandable with diameters ranging from 9 to 16 mm.
RESULTS: All but one of the procedures was technically successful (95%, n = 21). The patient with an unsuccessful procedure died 1 month after the procedure, but the death was not procedure-related. During follow-up three patients died with a patent shunt and central vein, none of them in connection with the procedure. No complication occurred during the interventional procedures. One patient was lost to follow-up. The primary patency rate at 12 months was 43%, with a primary assisted patency rate of 83% and a secondary patency rate of 100% (n = 6).
CONCLUSION: Central vein stenoses and occlusions are associated with previous subclavian vein cannulation. They are a serious problem in hemodialysis patients with a shunt on the same arm. Endovascular treatment is a suitable option for these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12491016     DOI: 10.1007/s00270-002-1960-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Brachiocephalic vein stenosis in association with ipsilateral hyperdynamic brachio-basilic fistula causing ipsilateral facial swelling and contralateral papillodema and visual loss. A case report.

Authors:  P Eames; L Senthil; A Thomas; P Riley; M A Burdon
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

2.  Percutaneous stenting of bilateral central venous occlusions in a hemodialysis patient.

Authors:  Yoshinobu Murasato; Takuo Tsurugi; Kinya Hiroshige; Fumihiko Kamezaki; Hiroshi Suzuka; Kiyoshi Kawanami; Yoshiyuki Suzuki
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

3.  Endovascular treatment of central venous obstruction as a complication of prolonged hemodialysis - Preliminary experience in a tertiary care center.

Authors:  Mukesh K Yadav; Madhurima Sharma; Anupam Lal; Vivek Gupta; Ashish Sharma; Niranjan Khandelwal
Journal:  Indian J Radiol Imaging       Date:  2015 Oct-Dec

4.  Comparison of Open-Cell Stent and Closed-Cell Stent for Treatment of Central Vein Stenosis or Occlusion in Hemodialysis Patients.

Authors:  Chae Hoon Kang; Seung Boo Yang; Woong Hee Lee; Jae Hong Ahn; Dong Erk Goo; Nae Jin Han; Joon Young Ohm
Journal:  Iran J Radiol       Date:  2016-09-11       Impact factor: 0.212

5.  The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients.

Authors:  Yonghui Huang; Bing Chen; Guosheng Tan; Gang Cheng; Yi Zhang; Jiaping Li; Jianyong Yang
Journal:  BMC Cardiovasc Disord       Date:  2016-12-07       Impact factor: 2.298

6.  Innominate Vein Stenosis in Association with Ipsilateral Hyperdynamic Brachiobasilic Fistula Causing Ipsilateral Limb and Hemifacial Swelling.

Authors:  J B Narendra; J Sreenivas; V S Karthikeyan; N H Nagaraja
Journal:  Indian J Nephrol       Date:  2017 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.